BB Medtech AG (VTX:MED) BB Medtech AG / Directors' dealings: Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
-------------------------------------------------------------------------------- Details of the person subject to the disclosure requirement --------------------------------------------------------------------------------
Ernst Thomke
Person with executive functions - Member of administrative or supervisory body
-------------------------------------------------------------------------------- Designation of the financial instrument --------------------------------------------------------------------------------
ISIN..........................: CH0038390016 Designation...................:
-------------------------------------------------------------------------------- Details of the transaction --------------------------------------------------------------------------------
Type of transaction...........: Buy Date..........................: 21.01.2009 Place (stock exchange)........: SIX Price.........................: 31,50 Currency......................: CHF Quantity......................: 60.000 Business volume...............: 1890000
BB Medtech AG Vordergasse 3 Schaffhausen CH-8200 Switzerland
Index: - Prime All Share - TECH All Share - TecDAX Listed: - Geregelter Markt in Frankfurter Wertpapierbörse - Prime Standard in Frankfurter Wertpapierbörse
--- End of Message ---
BB Medtech AG Vordergasse 3 Schaffhausen Switzerland
WKN: 898194 ; ISIN: CH0000428661; Index: TECH All Share, TecDAX, Prime All Share; Listed: Prime Standard in Frankfurter Wertpapierbörse, Geregelter Markt in Frankfurter Wertpapierbörse;
BB Medtech AG
www.bbmedtech.com
ISIN: CH0000428661
Stock Identifier: XFRA.MTH
-------------------------------------------------------------------------------- Details of the person subject to the disclosure requirement --------------------------------------------------------------------------------
Ernst Thomke
Person with executive functions - Member of administrative or supervisory body
-------------------------------------------------------------------------------- Designation of the financial instrument --------------------------------------------------------------------------------
ISIN..........................: CH0038390016 Designation...................:
-------------------------------------------------------------------------------- Details of the transaction --------------------------------------------------------------------------------
Type of transaction...........: Buy Date..........................: 21.01.2009 Place (stock exchange)........: SIX Price.........................: 31,50 Currency......................: CHF Quantity......................: 60.000 Business volume...............: 1890000
BB Medtech AG Vordergasse 3 Schaffhausen CH-8200 Switzerland
Index: - Prime All Share - TECH All Share - TecDAX Listed: - Geregelter Markt in Frankfurter Wertpapierbörse - Prime Standard in Frankfurter Wertpapierbörse
--- End of Message ---
BB Medtech AG Vordergasse 3 Schaffhausen Switzerland
WKN: 898194 ; ISIN: CH0000428661; Index: TECH All Share, TecDAX, Prime All Share; Listed: Prime Standard in Frankfurter Wertpapierbörse, Geregelter Markt in Frankfurter Wertpapierbörse;
BB Medtech AG
www.bbmedtech.com
ISIN: CH0000428661
Stock Identifier: XFRA.MTH
| Tweet |
![]() |
Related Companies |
>>> BB Medtech Ag |
![]() |
Related Industry Topics: |
European Finance News | |
![]() |
Diese Seite wurde besucht: (letzten 7 Tagen: 20) (letzten 30 Tagen: 70) (seit Veröffentlichung: 3090) |
Site Search
| DEUTSCH All Languages |
Upcoming WebCasts
| Mr Mark Paton CEO Cue Energy Resources Tuesday, June 12, 2012 |
| Mr Alan Hopkins CEO Pan Asia Corporation Tuesday, June 12, 2012 |
| Mr Barry Dawes Martin Place Securities Tuesday, June 12, 2012 |
| Dr Andrea Grant CEO Living Cell Technologies Monday, July 02, 2012 |
Companies in the News
Mobile Video TV
|
||
|
||






